Knowledge Centre
Browse through our collection of news, perspectives and webinars to gain a deeper understanding of the Innovate UK Business Connect culture and sector intelligence.
News
Materials Research Exchange 2018 – SAVE THE DATES
The Materials Research Exchange is to showcase the best of the UK materials innovation from both the academic and industrial community.
Read more
News
Building a synthetic biology-rich biotech business from scratch
The SYNBIOCHEM-SynbiCITE 4-day MBA course is designed to provide the skills required to establish, build and manage a biotech company.
Read more
News
Exploiting data to improve cancer care
Organisations can apply for a share of £425,000 to develop new ways of using existing data to improve cancer care in Scotland.
Read more
News
Facilitating valuable research collaborations with laboratory exchanges
EMBO EuropaBio Fellowships support research visits to another laboratory in the research areas of Systems Biology and Genomic & Computational Biology.
Read more
News
Government paper outlines how continued collaboration in science and innovation is an important part of the UK’s future partnership with the EU
“UK businesses and universities should continue to bid for competitive EU funds while we remain a member of the EU”.
Read more
News
Health Hack for injury and illness rehabilitation technologies
Innovators can team up with hardware, software, and mechanical engineers to develop ideas for new medical devices and technologies at Health Hack.
Read more
News
KTN & 'Innovate UK family' events on digital manufacturing, Autumn 2017
Lynne McGregor, Innovation Lead for Manufacturing and Materials at Innovate UK, asks ‚ÄòHow can we bring UK manufacturers to the forefront of Industry’?
Read more
News
Investigating composition and structure at the surface of materials
EPSRC’s new National Research Facility in X-ray photoelectron spectroscopy is hosting a training day on 11th October in Harwell.
Read more
News
ISCF Leading-edge Healthcare funding adds to range of sector opportunities
£197 million to develop first-of-a-kind technologies that will speed up patient access to new medicines.